Betrixaban: A Novel Factor Xa Inhibitor for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients. Cardiol Rev • August 2, 2018
Using biomarkers to "guide" heart failure management: current perspectives and future directions. Cardiol Rev • September 27, 2013
Rivaroxaban: an oral direct factor Xa inhibitor for the prevention of thromboembolism. Cardiol Rev • August 25, 2009
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1. Cardiol Rev • August 14, 2008
Cardiovascular considerations in patients undergoing gastrointestinal endoscopy. Cardiol Rev • April 11, 2008